20 March 2024: Aker BioMarine ASA today publishes its Annual Report for 2023,
which includes the annual accounts, the report on ESG (Environmental, Social and
Governance) and the auditor's report for 2023.

The report is attached and is also available at www.akerbiomarine.com.

Aker BioMarine ASA has also published its annual financial statements in
European
Single Electronic Format (ESEF), available as an attachment to this release.

For further information, please contact 
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820 
Email:  Christopher.vinter@akerbiomarine.com  
 
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.